A study to demonstrate the safety and efficacy of lopinavir/ritonavir (LPV/r) monotherapy as second-line of treatment in a resource-limited setting.

Trial Profile

A study to demonstrate the safety and efficacy of lopinavir/ritonavir (LPV/r) monotherapy as second-line of treatment in a resource-limited setting.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2015

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 18 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top